“Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors”, Mediterr J Hematol Infect Dis, vol. 18, no. 1, p. e2026001, Jan. 2026, doi: 10.4084/MJHID.2026.001.